The chief executive of health watchdog Nice told ITV News he is "disappointed" that drug manufacturer Roche has not offered the NHS a discount on a breast cancer drug that costs around £90,000 per patient.
Kadcyla, which extends women's lives by almost six months, could be blocked from routine NHS access because it is too expensive.
"Companies can discount their prices and they frequently do. Given the list price. I would have expected the company to have at least considered (a discount)," Andrew Dillon said.
More top news
Broadcaster Paul O'Grady has accused young people who practise unprotected sex of shaming the memory of his friends who died from Aids.
A group of travellers who formed an illegal camp on the grounds of a Birmingham school have been removed.
A school in Birmingham has been forced to partially close after travellers on the car park refused to move.